Guillaume Roberge

Chercheur associé
Axe Santé des populations et pratiques optimales en santé

Publications

Voir tout

article Kanack A, Mauch E, Roberge G, Splinter N, Gundabolu K, Wool GD, George G, Abou-Ismail MY, Smock KJ, Green DL, Coker J, Kohlhagen MC, Murray DL, Padmanabhan A

Platelet Factor 4 Antibody Persistence and Long-term Pathogenicity in Vaccine-induced Immune Thrombotic Thrombocytopenia

J Thromb Haemost 24 (7), 2026.

DOI PUBMED
article Kanack A, Mauch E, Roberge G, Splinter N, Gundabolu K, Wool GD, George G, Abou-Ismail MY, Smock KJ, Green DL, Coker J, Kohlhagen MC, Murray DL, Padmanabhan A

Platelet Factor 4 Antibody Persistence and Long-term Pathogenicity in Vaccine-induced Immune Thrombotic Thrombocytopenia

medRxiv 2025.

DOI PUBMED
article Wang TF, Yeo E, Gross PL, Séguin C, Wu C, Shivakumar S, Mallick R, Delluc A, D'Astous J, Kimpton M, Roberge G, Siegal DM, Tritschler T, Le Gal G, Carrier M

A Multicenter Prospective Cohort Study on the Use of Weight-Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism-The WAVe Study

Am J Hematol 101 (1), 2026.

DOI PUBMED